Efficacy of Almonertinib Versus Osimertinib as the First‐Line Treatment for Non‐Small Cell Lung Cancer With EGFR L858R Mutation and Prognostic Analysis: A Retrospective Comparative Cohort Study

Fuente: Wiley Open Access
Saved in:
Bibliographic Details
Main Authors: Xiujing Yao, Ruyue Li, Xue Dong, Ying Li, Yintao Li
Format: Artículo Open Access
Published: Wiley 2025
Subjects:
Online Access:
Tags: Add Tag
No Tags, Be the first to tag this record!